Endoscopic Sleeve Gastroplasty for Treatment of Obesity
NCT ID: NCT02231970
Last Updated: 2014-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2014-09-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study hypothesis is if endoscopic sleeve gastroplasty is effective and useful in the treatment of patients with obesity
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of Laparoscopic Truncal Vagotomy for the Treatment of Obesity
NCT00285220
Benefits of Endoscopic Bariatric Procedures
NCT05514288
NitiNotes' EndoZip System for the Treatment of Obesity
NCT03472196
Use of an Endoluminal-suturing Device for Endoscopic Gastric Reduction as an Aid for Class I Obesity, or Class II Obesity Without Comorbidity
NCT03900481
MOTIVATE Weight Loss Study
NCT01679158
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endoscopic sleeve gastroplasty
The intervention is an endoscopic procedure: to perform endoscopic sleeve gastroplasty we used a cap-based flexible endoscopic suturing system (OverStitch™, Apollo, Inc. Austin, Texas) mounted on a double-channel endoscope (GIF-2T160; Olympus Medical Systems Corporation, Tokyo, Japan) to achieve full-thickness, running sutures through the gastric wall from antrum to fundus.
Endoscopic sleeve gastroplasty
To perform endoluminal gastric volume reduction by the Endoscopic sleeve gastroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Endoscopic sleeve gastroplasty
To perform endoluminal gastric volume reduction by the Endoscopic sleeve gastroplasty
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
\-
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grupo Hospital de Madrid
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sofia Perea, Director Clinical Trials Unit.
Director, Clinical Trial Unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GONTRAND LOPEZ-NAVA, MD
Role: PRINCIPAL_INVESTIGATOR
HOSPITAL UNIVERSITARIO SANCHINARRO
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital Universitario Sanchinarro
Madrid, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
657-GHM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.